This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Chinese firm Hasten Biopharmaceutic has raised $315m for businessdevelopment of its pipeline assets in a financing round co-led by Singapore-based CBC Group and Abu Dhabi sovereign wealth fund Mubadala Investment, The funding round was supported by additional institutional investors.
Boris Zaïtra, who now leads corporate businessdevelopment, is confident his team of dealmakers can juggle them. Roche's core research spans five large areas.
People working on businessdevelopment are the ones responsible for dealing with the business side of the organization. Dealing with a lot of people, clients and a huge team is part of this job.
In the role, he'll oversee the drugmaker's portfolio management and businessdevelopment activities. .” | Citi analyst Andrew Baum, after covering Pfizer for more than a decade, will join the Big Pharma company as chief strategy and innovation officer.
Much anticipated clinical trial data for Immunovant’s experimental FcRn inhibitor could catalyze businessdevelopment decisions for its parent, Roivant Sciences.
Teva’s CEO Richard Francis is adding to his constellation of new executives with a fresh businessdevelopment hire from BeiGene. as its EVP of businessdevelopment, the Israeli-American generics giant announced Friday. Teva has enlisted BeiGene's Angus Grant, Ph.D,
The company also intends to use the funding to develop its precision neuroscience platform. Recently, it completed subject enrolment in a Phase IIa clinical trial of NMRA-140, which is a kappa opioid receptor antagonist in development to treat the major depressive disorder. Neumora has raised nearly $650m in capital to date.
Aqilion and Merck have entered an exclusive licence and strategic research partnership for the discovery, development and commercialisation of the transforming growth factor-β-activated kinase 1 (TAK1) protein-small molecule inhibitors. Aqilion will handle the design and synthesis of the new small molecule TAK1 inhibitors.
Divya Iyer, VP Strategy & BusinessDevelopment at GoodRx, showcases digital health innovations at Digital Pharma East conference. Thu, 11/10/2022 - 13:14.
Zerion Pharma has entered a partnership with Insud Pharma for the development and marketing of drug products using Zerion Pharma's solubility-boosting Dispersome technology. . Under the deal, Zerion will handle the development of Dispersome formulations of marketed drugs.
Innate Pharma has signed an exclusive licence agreement with Takeda to enable research and development of antibody drug conjugates (ADCs) against an undisclosed target, primarily focusing on coeliac disease. In addition, Innate will receive royalties on possible net sales of any commercial product to be developed under the licence.
Reno, NV, June 27, 2022 — Crucial Data Solutions (CDS), a provider of innovative low-code/no-code technologies to advance clinical research, announced today that industry veteran Brian Dufrense has joined the company as Senior Vice President, BusinessDevelopment.
In addition, we continue to make progress toward our goal of adding at least $25 billion in risk-adjusted 2030 revenues to Pfizer’s portfolio through businessdevelopment.”.
Through this equity contribution, TANAKA will reinforce its overseas businessdevelopment in addition to its domestic businessdevelopment and contribute to the development of a safe and secure healthcare industry. -based venture capital management company (“Ambix Ventures”).
PTC Therapeutics has signed a strategic financing partnership worth up to $1bn with funds managed by Blackstone to back the development of the former’s innovative product pipeline. PTC will use the network and life sciences capabilities of Blackstone to expand its businessdevelopment works.
“We believe that the combination of these expected near-term launches, additional pipeline products that could potentially come to market in the medium-term, and anticipated contributions from businessdevelopment, has the potential to set the company up for continued robust growth through the rest of this decade and beyond.”
Now, he leads Whitelab Genomics as its artificial intelligence (AI) platform powers the development of genomic therapies – an emerging field in which genetic sequences are injected into cells to target and repair damaged genes. We have been very impressed by their vision and the relevance of their platform.”.
Contract Development and Manufacturing Organizations (CDMOs) play a crucial role in helping companies overcome these regulatory hurdles. They can help ensure that these submissions are complete, accurate, and timely, which is critical for advancing drug development programs. CDMOs and How They Support BusinessDevelopment.
In today’s podcast, web editor Nicole Raleigh speaks with PASQAL’S technical businessdeveloper Europe, Krisztian Benyo, PhD, about the pharma applications and commercialisation of quantum science.
Simplicity and technology intersect to streamline drug development. Jim Reilly, vice president, development cloud strategy, believes that “the intersection of operational simplification and technology advancement will create cross-functional efficiency across clinical, regulatory, quality, and safety.
Every site should have a strategy for finding new studies regardless of the current number of actively enrolling studies. Established sites tend to have a larger network that can help them find new studies based on the site’s reputation.
Partnering is an important way to grow a business, and John Sharkey, Ph.D., newly-hired VP of businessdevelopment for GeoVax, is well-positioned to identify strong partners.
In addition, job seekers are also scrambling to find strategies for further developing their career pathways. COVID-19 has changed the way clinical research sites look for studies. In this webinar, Chris and myself share some pragmatic approaches for all to implement in order to take advantage of a HOT clinical trials industry!
At CAR-TCR last month in Boston, pharmaphorum Editor in Chief Jonah Comstock grabbed some time with Tim McGuire, director of businessdevelopment at biomanufacturer Resilience.
On today's podcast, brought to you by Kadans Science Partners, host Jonah Comstock is joined by Bradley Hardiman, Astellas Pharma’s Senior Director of BusinessDevelopment; Mike Murray, head of Murray International Partners Ltd; and Mairi Dillon, Kadans' Ecosystem Manager for UK & Ireland.
Oftentimes as clinical research professionals we do not think of ourselves as sales people but expanding your opportunities in the life sciences industry is as important as anything else we will ever do for our careers.
Clinical research is a large industry with a multitude of career options to choose from. Most people who enter the industry might only be familiar with CRC or CRA roles but the reality is that there are other supporting roles that are equally as essential for supporting the industry.
Ahead of CPHI North America, we caught up with Lisa Stiles, director, businessdevelopment at Selkirk Pharma, an exhibitor at the event, to find out how the CMO is navigating regulatory changes, challenges and more.
Though not for lack of businessdevelopment capacity, Pfizer is currently taking a large dealmaking “breathing period,” CEO Albert Bourla told investors this week at Goldman Sachs’ 2024 annual Global Healthcare Conference in Miami.
Pfizer Inc says it will maintain its supply of medicines to Russia but it will not initiate new clinical trials in the country, while Bayer is suspending investment projects and new-businessdevelopment in that market.
On today’s podcast, host Jonah Comstock is joined by Cody Powers, principal of portfolio and businessdevelopment at ZS Associates, to discuss those trends and predictions and how they’re shaking out so far.
FivepHusion has collaborated with Treehill Partners and Syneos Health to strategically progress development and commercialisation of its chemotherapeutic formulation Deflexifol in markets across the globe. Syneos will support the commercialisation and clinical development capabilities of FivepHusion.
The funding will offer capital to extend Blueprint’s varied pipeline toward marketing as well as to continue seeking strategic and synergistic businessdevelopment prospects. The company noted that the deal will bring substantial non-dilutive, low-cost capital to boost innovation and growth.
Thomas Kassberg, Chief Business Officer, Ultragenyx. Thomas Kassberg, Chief Business Officer, Ultragenyx. I think you really need to get the feedback directly from patients and then incorporate that feedback as you think about how you’re going to develop the product to be successful. Tom Kassberg, Ultragenyx. Dan Curran, Takeda.
On the back of its $350 million deal for two late-stage Idorsia assets, Viatris will continue to be “opportunistic” when it comes to making future businessdevelopment grabs—especially on the comme | On the back of its $350 million deal for two late-stage Idorsia assets, Viatris will continue to be “opportunistic” when it comes to making future business (..)
OSP was delighted to talk to Vetterâs Carsten Press, a senior leader of the global sales organization, and businessdevelopment among many operational functions.
Dawn Kaminski is vice president, of businessdevelopment (BD) operations at eClinical Solutions and is responsible for working with the BD team as a subject matter expert for services and technology, strategically positioning the organization to acquire new business and expand the business offerings within current customers.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content